Christopher P Cannon Selected Research

Christopher P Cannon Research Topics

Disease

238	Acute Coronary Syndrome 01/2023 - 02/2002
229	Myocardial Infarction 03/2024 - 03/2002
98	Stroke (Strokes) 03/2024 - 07/2003
86	Hemorrhage 01/2022 - 12/2002
83	Heart Failure 11/2023 - 03/2002
78	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 04/2002
72	Type 2 Diabetes Mellitus (MODY) 04/2024 - 12/2007
72	ST Elevation Myocardial Infarction 08/2021 - 03/2002
54	Unstable Angina 08/2018 - 10/2002
53	Atrial Fibrillation 01/2023 - 09/2004
50	Thrombosis (Thrombus) 07/2022 - 07/2002
46	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2002
42	Infections 01/2021 - 04/2002
38	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2003
31	Non-ST Elevated Myocardial Infarction 01/2017 - 10/2002
24	Hypertension (High Blood Pressure) 01/2023 - 02/2003
22	Chronic Renal Insufficiency 04/2024 - 01/2010
20	Inflammation (Inflammations) 01/2023 - 02/2003
20	Diabetes Mellitus 01/2022 - 10/2002
18	Infarction (Infarctions) 08/2009 - 04/2002
16	Ischemic Stroke 10/2022 - 09/2004
15	Neoplasms (Cancer) 07/2022 - 12/2003
15	Atherosclerosis 01/2020 - 02/2003
12	Renal Insufficiency (Renal Failure) 01/2023 - 02/2003
12	Dyslipidemias (Dyslipidemia) 12/2022 - 11/2007
12	Albuminuria 11/2022 - 10/2010
12	Atherosclerotic Plaque (Atheroma) 12/2021 - 06/2004
11	Peripheral Arterial Disease 01/2022 - 08/2004
11	Ischemia 01/2014 - 06/2002
10	Kidney Diseases (Kidney Disease) 11/2023 - 12/2017
10	Hypercholesterolemia 01/2022 - 04/2003
10	Left Ventricular Dysfunction 05/2017 - 01/2003
9	Obesity 12/2019 - 03/2006
7	Body Weight (Weight, Body) 01/2022 - 03/2005
7	Vascular Diseases (Vascular Disease) 01/2017 - 04/2003
7	Arthritis (Polyarthritis) 12/2012 - 08/2006
7	Osteoarthritis 06/2011 - 08/2006

Drug/Important Bio-Agent (IBA)

100	Clopidogrel (Plavix)FDA Link 08/2021 - 10/2002
87	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 04/2004
69	LipidsIBA 01/2023 - 04/2003
64	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 09/2002
55	TicagrelorIBA 10/2023 - 11/2007
46	Atorvastatin (Lipitor)FDA Link 01/2018 - 04/2002
43	LDL CholesterolIBA 01/2023 - 10/2004
43	Pravastatin (Pravachol)FDA LinkGeneric 01/2018 - 04/2002
42	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
37	oxidized low density lipoproteinIBA 01/2023 - 12/2003
32	Tirofiban (Aggrastat)FDA Link 11/2020 - 07/2002
32	C-Reactive ProteinIBA 12/2018 - 04/2002
27	Ezetimibe (Zetia)FDA Link 01/2023 - 08/2014
24	omega-Chloroacetophenone (Mace)IBA 03/2024 - 12/2009
23	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 12/2005
21	CanagliflozinIBA 01/2023 - 12/2017
21	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 01/2009
20	CreatinineIBA 01/2023 - 10/2003
20	Dabigatran FDA Link 01/2022 - 11/2010
19	AnticoagulantsIBA 01/2023 - 12/2007
19	darapladibIBA 12/2021 - 10/2010
19	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 02/2002
16	ertugliflozinIBA 10/2023 - 12/2018
15	alogliptinIBA 01/2020 - 10/2011
15	Glycoproteins (Glycoprotein)IBA 07/2016 - 12/2002
15	Heparin (Liquaemin)FDA LinkGeneric 01/2011 - 09/2002
14	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 06/2004
14	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2006
14	TroponinIBA 09/2017 - 07/2002
13	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2021 - 11/2008
12	HDL CholesterolIBA 07/2022 - 01/2007
12	orbofibanIBA 10/2006 - 12/2002
11	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2019
10	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2019
10	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 04/2008
10	Troponin IIBA 01/2018 - 04/2002
9	Growth Differentiation Factor 15IBA 01/2023 - 01/2011
9	Angiotensin Receptor AntagonistsIBA 01/2023 - 06/2009
9	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 02/2014
9	alirocumabIBA 09/2020 - 06/2015
9	EtoricoxibIBA 12/2012 - 08/2006
9	N(2)-(3-trifluoromethylphenyl)guanineIBA 05/2008 - 04/2002
8	Troponin T (Troponin T1)IBA 12/2022 - 07/2002
8	Vitamin K FDA Link 01/2021 - 10/2017
8	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 04/2006
8	Diclofenac (SR 38)FDA LinkGeneric 12/2012 - 08/2006
7	CholesterolIBA 01/2023 - 12/2004
7	SodiumIBA 01/2023 - 12/2018
7	Triglycerides (Triacylglycerol)IBA 09/2015 - 01/2007
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014 - 08/2006
7	RimonabantIBA 04/2008 - 03/2006
7	Platelet Membrane Glycoprotein IIbIBA 03/2008 - 10/2002
6	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 04/2024 - 01/2021
6	Hemoglobins (Hemoglobin)IBA 11/2023 - 11/2008
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2023 - 12/2016

Therapy/Procedure

282	Therapeutics 01/2024 - 03/2002
71	Percutaneous Coronary Intervention 07/2022 - 04/2002
30	Stents 07/2022 - 05/2006
27	Thrombolytic Therapy 08/2009 - 10/2002
26	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 12/2002
24	Patient Readmission 01/2017 - 09/2002
22	Secondary Prevention 01/2023 - 02/2004
8	Conservative Treatment 09/2017 - 07/2002